News & Updates

Alternating R-DA-EDOCH/R-DHAP induces deep remission in young Chinese patients with MCL

23 Mar 2025 by

A phase III trial demonstrated a high minimal residual disease (MRD)-negativity rate with intensive continuous dose-adjusted rituximab plus etoposide, dexamethasone, doxorubicin, cyclophosphamide, and vincristine (R-DA-EDOCH) alternated with rituximab, dexamethasone, cytarabine, and cisplatin (R-DHAP), thereby offering an alternative induction therapy choice for young Chinese patients with mantle-cell lymphoma (MCL).

Alternating R-DA-EDOCH/R-DHAP induces deep remission in young Chinese patients with MCL

23 Mar 2025

Curcumin reduces vincristine-induced neuropathy in paediatric ALL

23 Mar 2025 by

A double-blind randomized controlled trial (RCT) reports a significantly lower incidence of vincristine-induced peripheral neuropathy (VIPN) in paediatric acute lymphoblastic leukaemia (ALL) patients who received curcumin vs placebo.

Curcumin reduces vincristine-induced neuropathy in paediatric ALL

23 Mar 2025

Levonorgestrel-releasing intrauterine system linked to increased breast cancer risk

23 Mar 2025

Exposure to the levonorgestrel-releasing intrauterine system, especially during the first few years, appears to contribute to a heightened risk of breast cancer among women with abnormal uterine bleeding, endometriosis, or leiomyomas, according to a retrospective study.

Levonorgestrel-releasing intrauterine system linked to increased breast cancer risk

23 Mar 2025

Personalized exercise intervention beneficial to lung cancer patients

22 Mar 2025

A personalized, perioperative, home-based exercise intervention for patients undergoing lung cancer helps improve physical function in women and prevent fatigue worsening in all groups, according to the results of the phase III Precision-Exercise-Prescription (PEP) trial.

Personalized exercise intervention beneficial to lung cancer patients

22 Mar 2025

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

21 Mar 2025

Increased consumption of lignans, specifically secoisolariciresinol (SECO), results in a significant reduction in overall cardiovascular disease (CVD) and cancer mortality among individuals with type 2 diabetes (T2D), a study has shown.

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

21 Mar 2025

Theranostics in prostate cancer management: Current strategies and real-world data

21 Mar 2025 by

Earlier use of lutetium-177 (¹⁷⁷Lu) prostate-specific membrane antigen (PSMA)–radioligand therapy (RLT) in combination with chemotherapy is shaping the future of prostate cancer management, according to Dr Yu-Yi Huang of the Department of Nuclear Medicine, Koo-Foundation Sun Yat-Sen Cancer Center (SYSCC), Taiwan, at Uro-Oncology Asia 2025.

Theranostics in prostate cancer management: Current strategies and real-world data

21 Mar 2025

DV plus toripalimab shows promise in metastatic urothelial carcinoma

20 Mar 2025

Combination treatment with disitamab vedotin (DV) and toripalimab results in positive objective response rates (ORR) and overall survival (OS), with an acceptable safety profile, in HER2-unselected locally advanced or metastatic urothelial carcinoma (mUC) patients, as shown by the results of a phase Ib/II study.

DV plus toripalimab shows promise in metastatic urothelial carcinoma

20 Mar 2025

ICIs plus statins may extend survival in cancer patients

20 Mar 2025

Treatment with statins combined with immune checkpoint inhibitors (ICIs), such as programmed cell death 1 (PD-1) and PD ligand 1 (PD-L1) inhibitors, is associated with improved survival in cancer patients, according to a study.

ICIs plus statins may extend survival in cancer patients

20 Mar 2025

NAC protects against chemo-induced neuropathy

19 Mar 2025

Treatment with oral N-acetylcysteine (NAC) 1,200 mg/day does not result in a significant reduction in the incidence or severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast cancer, a recent study has shown.

NAC protects against chemo-induced neuropathy

19 Mar 2025

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025 by

In colorectal cancer, the traditional method for removing the tumour is open surgery. However, the surgical treatment landscape has evolved over the years and transitioned to embrace the utilization of minimally invasive approaches such as laparoscopic or keyhole surgery and the use of robotics.

Managing advanced colorectal cancer with robotic surgery

19 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Alternating R-DA-EDOCH/R-DHAP induces deep remission in young Chinese patients with MCL

Alternating R-DA-EDOCH/R-DHAP induces deep remission in young Chinese patients with MCL

Curcumin reduces vincristine-induced neuropathy in paediatric ALL

Curcumin reduces vincristine-induced neuropathy in paediatric ALL

Levonorgestrel-releasing intrauterine system linked to increased breast cancer risk

Levonorgestrel-releasing intrauterine system linked to increased breast cancer risk

Personalized exercise intervention beneficial to lung cancer patients

Personalized exercise intervention beneficial to lung cancer patients

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

Lignan intake helps prevent CVD, cancer deaths in diabetic adults

Theranostics in prostate cancer management: Current strategies and real-world data

Theranostics in prostate cancer management: Current strategies and real-world data

DV plus toripalimab shows promise in metastatic urothelial carcinoma

DV plus toripalimab shows promise in metastatic urothelial carcinoma

ICIs plus statins may extend survival in cancer patients

ICIs plus statins may extend survival in cancer patients

NAC protects against chemo-induced neuropathy

NAC protects against chemo-induced neuropathy

Managing advanced colorectal cancer with robotic surgery

Managing advanced colorectal cancer with robotic surgery